Veru (VERU) Inventory (2010 - 2024)
Veru (VERU) posted quarterly Inventory of $4.1 million for Q3 2024, down 39.77% year-over-year from $6.9 million in Q4 2023, and down 35.14% quarter-over-quarter from $6.4 million in Q2 2024.
Veru (VERU) Inventory (2010 - 2024) Analysis & Trends
Veru (VERU) has reported Inventory for 15 consecutive years, with $4.1 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Inventory fell 39.77% year-over-year to $4.1 million; the TTM figure through Sep 2024 stood at $4.1 million (down 39.77% YoY), while the FY2024 annual figure was $4.1 million, down 39.77% from the prior year.
- Inventory slipped to $4.1 million in Q3 2024 per VERU's latest filing, from $6.4 million in the prior quarter.
- Across five years, Inventory topped out at $8.7 million in Q4 2022 and bottomed at $4.1 million in Q3 2024.
- Historically, Inventory has averaged $6.6 million across 5 years, with a median of $6.7 million in 2023.
- Annual changes were most pronounced in 2020 — Inventory soared 100.66% — and 2024, when it slumped 39.77%.
- Veru's Inventory stood at $6.7 million in 2020, then slipped by 26.49% to $4.9 million in 2021, then jumped by 78.57% to $8.7 million in 2022, then slipped by 19.23% to $7.1 million in 2023, then tumbled by 41.36% to $4.1 million in 2024.
- Business Quant data shows VERU's Inventory at $4.1 million in Q3 2024, $6.4 million in Q2 2024, and $4.8 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Veru | 61.43 Mn | 35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 4.14 Mn |
| Jun 30, 2024 | 6.39 Mn |
| Mar 31, 2024 | 4.80 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Sep 30, 2023 | 6.88 Mn |
| Jun 30, 2023 | 6.70 Mn |
| Mar 31, 2023 | 7.67 Mn |
| Dec 31, 2022 | 8.75 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 7.72 Mn |
| Mar 31, 2022 | 6.42 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 5.57 Mn |
| Jun 30, 2021 | 6.95 Mn |
| Mar 31, 2021 | 7.79 Mn |
| Dec 31, 2020 | 6.67 Mn |
| Sep 30, 2020 | 6.70 Mn |
| Jun 30, 2020 | 5.19 Mn |
| Mar 31, 2020 | 6.02 Mn |
| Dec 31, 2019 | 4.60 Mn |